Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shan-Liang Sun"'
Autor:
Tian‐Hua Wei, Meng‐Yi Lu, Si‐Hui Yao, Yu‐Qi Hong, Jin Yang, Meng‐Yuan Zhang, Yu‐Qi Yin, Yu‐Jie Han, Qing‐Qing Li, Zi‐Xuan Wang, Yi‐Bo Wang, Zhen‐Jiang Tong, Yun Zhou, Wei‐Chen Dai, Yan‐Cheng Yu, Shan‐Liang Sun, Ye Yang, Nian‐Guang Li, Zhi‐Hao Shi
Publikováno v:
MedComm – Oncology, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract Janus Kinases (JAKs) play a crucial role as therapeutic targets for various cancers. However, the current JAK inhibitors (JAKi) available have limited therapeutic benefits due to their lack of selectivity. This review focuses on the structur
Externí odkaz:
https://doaj.org/article/29262a2be1a6426fa1afb92378ccb3fb
Autor:
Shan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, Hai Zhou, Chen-Qian Zhang, Zhen-Jiang Tong, Yi-Bo Wang, Jiu-Kai Sha, Qing-Xin Wang, Jia-Chuan Liu, Xin-Rui Zheng, Qing-Qing Li, Meng-Yuan Zhang, Jin Yang, Tian-Hua Wei, Zi-Xuan Wang, Yan-Cheng Yu, Ning Ding, Xue-Jiao Leng, Xin Xue, He-Min Li, Wei-Chen Dai, Xiao-Ying Yin, Ye Yang, Jin-Ao Duan, Nian-Guang Li, Zhi-Hao Shi
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 169, Iss , Pp 115905- (2023)
The therapeutic benefits of available FLT3 inhibitors for AML are limited by drug resistance, which is related to mutations, as well toxicity caused by off-target effects. In this study, we introduce a new small molecule FLT3 inhibitor called danatin
Externí odkaz:
https://doaj.org/article/b4a16bb41b1041b8acc5195b558148af
Autor:
Qing‐Xin Wang, Yi‐Bo Wang, Jiu‐Kai Sha, Hai Zhou, Jia‐Chuan Liu, Jia‐Zhen Wu, Zhen‐Jiang Tong, Jiao Cai, Zi‐Jun Chen, Chen‐Qian Zhang, Xin‐Rui Zheng, Jing‐Jing Wang, Xiao‐Long Wang, Xin Xue, Yan‐Cheng Yu, Ning Ding, Xue‐Jiao Leng, Wei‐Chen Dai, Shan‐Liang Sun, Liang Chang, Nian‐Guang Li, Zhi‐Hao Shi
Publikováno v:
Drug Development Research. 84:296-311
Autor:
Qing-Xin Wang, Yu-Hao Cao, Li-Jin Yang, Yi-Yuan Ma, Nan Li, Shi-Han Wu, Lu Chen, Jia-Zhen Wu, Zhen-Jiang Tong, Xiao-Long Wang, Xin Xue, Ning Ding, Xue-Jiao Leng, Liang Chang, Wei-Chen Dai, Yan-Cheng Yu, Shan-Liang Sun, Ye Yang, Nian-Guang Li, Zhi-Hao Shi
Publikováno v:
Future Medicinal Chemistry. 15:57-71
Aim: The clinical benefits of FLT3 inhibitors against acute myeloid leukemia (AML) have been limited by selectivity and resistance mutations. Thus, to identify FLT3 inhibitors possessing high selectivity and potency is of necessity. Methods & results
Autor:
Zhi-Hao Shi, Nian-Guang Li, Shan-Liang Sun, Shi-Han Wu, Li-Jin Yang, Yi-Yuan Ma, Yu-Hao Cao, Zhen-Jiang Tong, Jia-Zhen Wu, Yi-Bo Wang, Jiu-Kai Sha, Ning Ding, Qiao-Li Liang, Liang Chang, Xiao-Long Wang, Jin-Ao Duan, Yan-Cheng Yu, Wei-Chen Dai, Ke Xie, Xue-Jiao Leng, Xin Xue
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Acute myeloid leukemia (AML) is the most common type of blood cancer. Fms-like tyrosine kinase 3 (FLT3) is a member of the class III receptor tyrosine kinase family. Overexpression of FLT3 was found in 70-100% of patients with acute myelo
Autor:
Shan-Liang Sun, Shi-Han Wu, Ji-Bo Kang, Yi-Yuan Ma, Lu Chen, Peng Cao, Liang Chang, Ning Ding, Xin Xue, Nian-Guang Li, Zhi-Hao Shi
Publikováno v:
Journal of Medicinal Chemistry. 65:7415-7437
Despite significant efficacy, one of the major limitations of small-molecule Bruton's tyrosine kinase (BTK) agents is the presence of clinically acquired resistance, which remains a major clinical challenge. This Perspective focuses on medicinal chem
Tomentosin suppressed M1 polarization via increasing MERTK activation mediated by regulation of GAS6
Autor:
Yu-xi Di, Yu-jie Bao, Zhi-qi Zhu, Shan-liang Sun, Feng-xiang Tian, Fu-rong Wang, Ge Yu, Ming-fei Zhang, Jing Han, Ling-ling Zhou
Publikováno v:
Journal of Ethnopharmacology. 314:116429
Autor:
Liang Chang, Qiao-Li Liang, Nian-Guang Li, Shan-Liang Sun, Xiao-Bin Dai, Shi-Han Wu, Ning Ding, Yi-Yuan Ma, Zhen-Jiang Tong, Jia-Zhen Wu, Yi-Bo Wang, Yan-Cheng Yu, Xue-Jiao Leng, Xin Xue, Jin-Guo Xu, Wei-Chen Dai, Ke Xie, Jing-Han Zhao, Yu-Qi Hong, Tian-Xi Lan, Tian-Yu Mu, Xiao-Long Wang
Publikováno v:
Letters in Drug Design & Discovery. 20
Background: Alzheimer’s disease (AD), a chronic neurodegenerative disorder predominantly occurs among the elderly, is the leading cause of dementia. The accumulation of β-amyloid (Aβ) is considered the main pathogenies of AD, and β-site APP-clea
Autor:
Xiao-Long Wang, Chao Zhao, Nian-Guang Li, Shan-Liang Sun, Han Xu, Hong-Yue Ma, He-Min Li, Huan-Huan Chen, Yue Zhong, Min Chen, Jiao-Jiao Wang
Publikováno v:
Chinese Journal of Natural Medicines. 19:454-463
Natural product bufotenine (5) which could be isolated from Venenum Bufonis, has been widely used as a tool in central nervous system (CNS) studies. We present here its quaternary ammonium salt (6) which was synthesized with high yields using 5-benzy
Autor:
Lu Chen, Yu-Hao Cao, Li-Jin Yang, Yang Cheng, Yi-Yuan Ma, Ji-Bo Kang, Qing-Xin Wang, Nan Li, Xiao Yang, Shi-Han Wu, Yue Zhong, Xiao-Long Wang, Xin Xue, Ning Ding, Qiao-Li Liang, Liang Chang, He-Min Li, Jin-Ao Duan, Shan-Liang Sun, Nianguang Li, Zhi-Hao Shi
Publikováno v:
SSRN Electronic Journal.